Letter: Treatment of maturity-onset diabetes.
作者信息
Luntz G R
出版信息
Lancet. 1975 Mar 29;1(7909):743. doi: 10.1016/s0140-6736(75)91649-9.
PMID:47501
Abstract
摘要
相似文献
1
Letter: Treatment of maturity-onset diabetes.
Lancet. 1975 Mar 29;1(7909):743. doi: 10.1016/s0140-6736(75)91649-9.
2
Letter: Treatment of maturity-onset diabetes.
Lancet. 1975 Mar 8;1(7906):580-1. doi: 10.1016/s0140-6736(75)91606-2.
3
Letter: Treatment of maturity-onset diabetes.
Lancet. 1975 Feb 15;1(7903):389-90. doi: 10.1016/s0140-6736(75)91298-2.
4
Comparative study of glibenclamide & chlorpropamide in newly diagnosed maturity onset diabetics.
J Pak Med Assoc. 1976 Feb;26(2):23-6.
5
Comparison of chlorpropamide and glibenclamide treatment of maturity-onset diabetes: control assessed by fasting plasma glucose concentrations.
Diabetes Care. 1981 Mar-Apr;4(2):293-5. doi: 10.2337/diacare.4.2.293.
6
Long-term comparative trial of glibenclamide and chlorpropamide in diet-failed, maturity-onset diabetics.
Lancet. 1975 Feb 1;1(7901):246-8. doi: 10.1016/s0140-6736(75)91141-1.
7
[Plasma insulin and glucose levels in diabetics treated with glibenclamide and chlorporpamide].
Acta Diabetol Lat. 1973 Jan-Feb;10(1):30-53. doi: 10.1007/BF02590651.
8
[Glibenclamide--a better antidiabetic agent?].
Lakartidningen. 1972 Dec 20;69(52):6147-9.
9
Diabetes mellitus: the thin maturity-onset diabetic.
Br Med J. 1972 Sep 16;3(5828):692-4. doi: 10.1136/bmj.3.5828.692.
10
[The glibenclamide-phenformin combination in the therapy of diabetes mellitus].
Minerva Med. 1974 Aug 29;65(59):383-9.
Zotero 插件